Access the full text.
Sign up today, get DeepDyve free for 14 days.
Brian Pace, Neşe Devenot (2021)
Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political PluripotencyFrontiers in Psychology, 12
D. Arora (2008)
Xiao Ren Ren: The “Little People” of YunnanEconomic Botany, 62
T. Metzinger (2023)
Bewusstseinskultur: Spiritualit�t, intellektuelle Redlichkeit und die planetare Krise
N. Langlitz, E. Dyck, M. Scheidegger, D. Repantis (2021)
Moral Psychopharmacology Needs Moral Inquiry: The Case of PsychedelicsFrontiers in Psychiatry, 12
N. Langlitz (2022)
Psychedelic innovations and the crisis of psychopharmacologyBioSocieties
(2022)
European drug report 2022: Trends and developments
S. Casper (2015)
NeuropsychedeliaSocial Studies of Science, 45
M. Dobkin de Rios (1984)
Hallucinogens: Cross-cultural perspectives
Tehseen Noorani, John Martell (2021)
New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the DichotomyFrontiers in Psychiatry, 12
Jacob Aday, Christopher Davoli, Emily Bloesch (2019)
2018: A watershed year for psychedelic scienceDrug Science, Policy and Law, 5
G.M. Goodwin (2022)
Single-dose psilocybin for a treatment-resistant episode of major depression, 387
D. Yaden, J. Potash, R. Griffiths (2022)
Preparing for the Bursting of the Psychedelic Hype Bubble.JAMA psychiatry
Manoj Doss, F. Barrett, P. Corlett (2022)
Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.ACS chemical neuroscience
N. Shalit, J. Rehm, S. Lev-Ran (2019)
Epidemiology of hallucinogen use in the U.S. results from the National epidemiologic survey on alcohol and related conditions III.Addictive behaviors, 89
H. Jungaberle (2008)
Die Professionalisierung Substanz-unterst�tzter Psychotherapie (SPT)
A. Letcher (2006)
Shroom: A cultural history of the magic mushroom
R.L. Carhart‐Harris (2021)
Trial of psilocybin versus escitalopram for depression, 384
Neşe Devenot, Trey Conner, Richard Doyle (2022)
Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source AlternativeAnthropology of Consciousness
P. Furst (1976)
Hallucinogens and culture
G. Miller (2010)
Is pharma running out of brainy ideas?Science, 329 5991
N. Langlitz (2012)
Neuropsychedelia: The revival of hallucinogen research since the decade of the brain
James Faubion (2013)
The subject that is not one: On the ethics of mysticismAnthropological Theory, 13
N. Langlitz (2020)
Warning against and experimenting with moralityHAU: Journal of Ethnographic Theory, 10
David Dupuis (2021)
Psychedelics as Tools for Belief Transmission. Set, Setting, Suggestibility, and Persuasion in the Ritual Use of HallucinogensFrontiers in Psychology, 12
R. Griffiths (2006)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance, 187
T. Metzinger (2009)
The ego tunnel: The science of the mind and the myth of the self
(1973)
Religion, altered states of consciousness, and social change
S. Snelders, Charles Kaplan, T. Pieters (2006)
On Cannabis, Chloral Hydrate, and Career Cycles of Psychotrophic Drugs in MedicineBulletin of the History of Medicine, 80
N. Langlitz (2020a)
Devil's advocate: Sketch of an amoral anthropology, 10
S. Kähkönen, I. Jääskeläinen, S. Pennanen, J. Liesivuori, J. Ahveninen (1995)
- Original Investigation -
N. Langlitz (2020)
Devil’s advocateHAU: Journal of Ethnographic Theory, 10
A. Gearin, Neşe Devenot (2021)
Psychedelic medicalization, public discourse, and the morality of ego dissolutionInternational Journal of Cultural Studies, 24
N. Langlitz (2019)
Psychedelic science as cosmic play, psychedelic humanities as perennial polemics? Or why we are still fighting over Max Weber's science as a vocation, 19
M. Nour, Lisa Evans, R. Carhart-Harris (2017)
Psychedelics, Personality and Political PerspectivesJournal of Psychoactive Drugs, 49
B. Latour, C. Venn (2002)
Morality and TechnologyTheory, Culture & Society, 19
As regulatory agencies have put psychedelics on an expedited path to market approval, North Americans and Europeans might turn away from their repression and join the subset of cultures that have institutionalized the use of hallucinogenic drugs. What is the place of anthropology in this psychedelic renaissance? More specifically, how should anthropology relate to the cycles of hype and anti‐hype, which have been identified as a recurrent pattern in the careers of new drugs as psychedelics have entered a second round of cultural enthusiasm and critique? This article suggests extending ethnographic studies of the psychedelic renaissance from medical to moral anthropology. The case of psychedelics is especially interesting for moral anthropology because these drugs frequently induce mystical‐type experiences, which can play an ethically irritating role as mysticism challenges a strict moral order enforced through disciplinary practices. What cultural consequences would the spread of mystical experiences have for contemporary European and North American societies?
Anthropology Today – Wiley
Published: Jun 1, 2023
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.